Studies on the Dual Cytotoxicity and Antioxidant Properties of Berberis vulgaris Extracts and Its Main Constituent Berberine

Advances in Pharmacological Sciences

Volumn 2018, Issue , 2018, Pages

  El Khalki, Lamyae ^a   Tilaoui, Mounir ^a   Jaafari, Abdeslam ^a   Ait Mouse, Hassan ^a   Zyad, Abdelmajid ^a  

^a SULTAN MOULAY SLIMANE UNIVERSITY   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTIOXIDANT; ASCORBIC ACID; BERBERINE; BERBERIS VULGARIS EXTRACT; CISPLATIN; COLUMBAMINE; CRYSTAL VIOLET; CYTOTOXIC AGENT; EPIBERBERINE; FLUORESCEIN ISOTHIOCYANATE; JATRORRHIZINE; LIPOCORTIN 5; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PALMATINE; PLANT EXTRACT; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BARK; BERBERIS VULGARIS; CELL VIABILITY; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DPPH RADICAL SCAVENGING ASSAY; DRUG ISOLATION; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MCF-7 CELL LINE; MTT ASSAY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLANT ROOT;

EID: 85042637569     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2018/3018498     Document Type: Article

References (50)

1. J. Belakhdar, La Pharmacopée Marocaine Traditionnelle, Ibis Press, MA, USA, 1998.
2. G. Cui, X. Qin, Y. Zhang, Z. Gong, B. Ge, and Y. Q. Zang, "Berberine di2erentially modulates the activities of ERK, p38 MAPK, and JNK to suppress +17 and +1 T cell di2erentiation in type 1 diabetic mice," Journal of Biological Chemistry, vol. 284, no. 41, pp. 28420-28429, 2009.
3. D. A. Ghareeb, A. E. A. El-Wahab, E. E. M. Sarhan, M. M. Abu Serie, and M. A. El Demellawy, "Biological assessment of BV and its active constituent, berberine: antibacterial, antifungal and antihepatitis C virus (HCV) effect," Journal of Medicinal Plants Research, vol. 7, pp. 1529-1536, 2013.
4. S. Letasiova, S. Jantova, L. Cipak, and M. Muckova, "Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells," Cancer Letters, vol. 239, no. 2, pp. 254-262, 2006.
5. K. C. Karnam, M. Ellutla, L. N. Bodduluru et al., "Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats," Biomedicine and Pharmacotherapy, vol. 92, pp. 207-214, 2017.
6. T. Singh, M. Vaid, N. Katiyar, S. Sharma, and S. K. Katiyar, "Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase 2, prostaglandin E2 and prostaglandin E2 receptors," Carcinogenesis, vol. 32, no. 1, pp. 86-92, 2011.
7. N. Wang, H.-Y. Tan, L. Li, M.-F. Yuen, and Y. Feng, "Berberine and Coptidis rhizoma as potential anticancer agents: recent updates and future perspectives," Journal of Ethnopharmacology, vol. 176, pp. 35-48, 2015.
8. F. Tang, D. Wang, C. Duan et al., "Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting rho kinase-mediated Ezrin phosphorylation at threonine 567," Journal of Biological Chemistry, vol. 284, no. 40, pp. 27456-27466, 2009.
9. E. Bremer, G. van Dam, B. J. Kroesen, L. de Leij, and W. Helfrich, "Targeted induction of apoptosis for cancer therapy: current progress and prospects," Trends in Molecular Medicine, vol. 12, no. 8, pp. 382-393, 2006.
10. Y. H. Shen, X. L. Wang, and D. E. L. Wilcken, "Nitric oxide induces and inhibits apoptosis through di2erent pathways," FEBS Letters, vol. 433, no. 1-2, pp. 125-131, 1998.
11. M. P. Murphy, "Nitric oxide and cell death," Biochimica et Biophysica Acta, vol. 1411, no. 2-3, pp. 401-414, 1999.
12. T. Mosmann, "Rapid colourimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays," Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55-63, 1983.
13. M. Tilaoui, H. Ait Mouse, A. Jaafari, and A. Zyad, "Comparative phytochemical analysis of essential oils from di2erent biological parts of Artemisia herba alba and their cytotoxic effect on cancer cells," PLoS ONE, vol. 10, p. e0131799, 2015.
14. I. Vermes, C. Haanen, H. Steens-Nakken, and C. Reutelingsperger, "A novel assay for apoptosis Iow cytometric detection of phosphatidylserine early apoptotic cells using Iuorescein labeled expression on Annexin V," Journal of Immunological Methods, vol. 184, no. 1, pp. 39-51, 1995.
15. K. Soon Kim, S. Lee, Y. Lee et al., "Anti-oxidant activities of the extracts from the herbs of Artemisia apiacea," Journal of Ethnopharmacology, vol. 85, no. 1, pp. 69-72, 2003.
16. A. Zyad, D. Branellec, Y. Mahé, T. Tursz, and S. Chouaib, "The development of human tumour-cell resistance to TNF-alpha does not confer resistance to cytokine-induced cellular cytotoxic mechanisms," International Journal of Cancer, vol. 52, no. 6, pp. 953-958, 1992.
17. T.-C. Chou and P. Talalay, "Quantitative analysis of dosee 2ect relationships: the combined effects of multiple drugs or enzyme inhibitors," Advances in Enzyme Regulation, vol. 22, pp. 27-55, 1984.
18. L. Grycova, J. Dostal, and R. Marek, "Quaternary protoberberine alkaloids," Phytochemistry, vol. 68, no. 2, pp. 150-175, 2007.
19. X. Luo, B. Chen, and S. Yao, "Simultaneous analysis of protoberberine, indolequinoline and quinolone alkaloids in coptis-evodia herb couple and the Chinese herbal preparations by high-performance liquid chromatography-electrospray mass spectrometry," Talanta, vol. 66, no. 1, pp. 103-110, 2005.
20. J.-M. Huang, G.-Q. Wang, Y.-E. Jin, T. Shen, and W. Weng, "Determination of palmatine in canine plasma by liquid chromatography-tandem mass spectrometry with solid-phase extraction," Journal of Chromatography B, vol. 854, no. 1-2, pp. 279-285, 2007.
21. Q.-F. Liu, X.-J. Shi, Z.-D. Li, M.-K. Zhong, Z. Jiao, and B. Wang, "Pharmacokinetic comparisons of berberine and palmatine in normal and metabolic syndrome rats," Journal of Ethnopharmachology, vol. 151, no. 1, pp. 287-291, 2014.
22. D. Patil, M. Gautam, S. Mishra et al., "Quantitative determination of protoberberine alkaloids in tinosporacordifolia by RP-LC-DAD," Chromatographia, vol. 71, no. 3-4, pp. 341-345, 2009.
23. A. Orucevic and P. K. Lala, "E2ects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumour responses in healthy and tumour-bearing mice," Cancer Immunology and Immunotherapy, vol. 42, no. 1, pp. 38-46, 1996.
24. D. C. Jenkins, I. G. Charles, L. L. Aomsen et al., "Roles of nitric oxide in tumour growth," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 10, pp. 4392-4396, 1995.
25. K. KashE, Y. Ryan, L. L. Qiao et al., "Nitric oxide-donating nonsteroidal anti-inIammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue typeindependent effect," Journal of Pharmacology and Experimental Berapeutics, vol. 303, no. 3, pp. 1273-1282, 2002.
26. N. Mokhber-Dezfuli, S. Saeidnia, A. Reza Gohari, and M. Kurepaz-Mahmoodabadi, "Phytochemistry and Pharmacology of Berberis Species," Pharmacognosy Reviews, vol. 8, no. 15, p. 8, 2014.
27. M. ImanShahidi and H. HosseinZadeh, "Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine," Phytotherapy Research, vol. 22, no. 8, pp. 999-1012, 2008.
28. P. Hanachi and S. H. Golkho, "Using HPLC to determination the composition and antioxidant activity of Berberis vulgaris," European Journal of ScientiDc Research, vol. 29, pp. 47-54, 2009.
29. C. J. Thirupurasundari, R. Padmini, S. Chithambaram, and N. Devaraj, "Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats," Chemico-Biological Interactions, vol. 177, no. 3, pp. 190-195, 2009.
30. A. Berłowski, K. Zawada, I. Wawer, and K. Paradowska, "Antioxidant properties of medicinal plants from Peru," Food and Nutrition Sciences, vol. 4, no. 8, pp. 71-77, 2013.
31. M. S. Choi, D. Y. Yuk, and J. H. Oh, "Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis," Anticancer Research, vol. 28, no. 6A, pp. 3777-3748, 2008.
32. S. Jantova, L. Cipak, and S. Letasiova, "Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells," Toxicology in Vitro, vol. 21, no. 1, pp. 25-31, 2007.
33. J. P. Lin, J. S. Yang, J. H. Lee, W. T. Hsieh, and J. G. Chung, "Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line," World Journal of Gastroenterology, vol. 12, no. 1, pp. 21-28, 2006.
34. N. Keawpradub, S. Dej-adisai, and S. Yuenyongsawad, "Antioxidant and cytotoxic activities of Thai medicinal plants named Khaminkhruea and Fibraureatinctoria," Songklanakarin Journal of Science and Technology, vol. 27, no. 2, pp. 455-467, 2005.
35. J.-P. Lin, J. S. Yang, N. W. Chang et al., "GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells," Anticancer Research, vol. 27, no. 5A, pp. 3379-3386, 2007.
36. Y.-T. Ho, C. C. Lu, J. S. Yang et al., "Berberine induced apoptosis via promoting the expression of Caspase-8,-9 and-3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells," Anticancer Research, vol. 29, no. 10, pp. 4063-4070, 2009.
37. J. Wu, Q. Xiao, N. Zhang et al., "Palmatine hydrochloride mediated photodynamic inactivation of breast cancer MCF-7 cells: effectiveness and mechanisms of action," Photodiagnosis and Photodynamic Berapy, vol. 15, pp. 133-138, 2016.
38. S. K. Katiyar, S. M. Meeran, N. Katiyar, and S. Akhtar, "p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumour xenograft growth in vivo," Molecular Carcinogenesis, vol. 48, no. 1, pp. 24-37, 2009.
39. S. K. Mantena, S. D. Sharma, and S. K. Katiyar, "Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdkcyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP," Carcinogenesis, vol. 27, no. 10, pp. 2018-2027, 2006.
40. H. L. Wu, C. Y. Hsu, W. H. Lin, and B. Y. Yung, "Berberineinduced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity," International Journal of Cancer, vol. 81, no. 6, pp. 923-929, 1999.
41. K. Fukuda, Y. Hibiya, M. Mutoh, M. Koshiji, S. Akao, and H. Fujiwara, "Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells," Journal of Ethnopharmacology, vol. 66, no. 2, pp. 227-233, 1999.
42. J. Lin, C. He, K. Zhou, J. Wang, and J. X. Kang, "Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells," Biochemical and Biophysical Research Communications, vol. 378, no. 2, pp. 174-178, 2009.
43. W. H. Hsu, Y. S. Hsieh, H. C. Kuo et al., "Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL," Archives of Toxicology, vol. 81, no. 10, pp. 719-728, 2007.
44. J. M. Hwang, H. C. Kuo, T. H. Tseng, J. Y. Lin, and C. Y. Chu, "Berberine induces apoptosis through a mitochondria/ caspases pathway in human hepatoma cells," Archives of Toxicology, vol. 80, no. 2, pp. 62-73, 2006.
45. S. K. Mantena, S. D. Sharma, and S. K. Katiyar, "Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells," Molecular Cancer Berapy, vol. 5, no. 2, pp. 296-308, 2006.
46. K. S. Eom, J. M. Hong, M. J. Youn et al., "Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway," Biological and Pharmaceutical Bulletin, vol. 31, no. 4, pp. 558-562, 2008.
47. C. C. Lin, S. T. Kao, G. W. Chen, H. C. Ho, and J. C. Chung, "Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3," Anticancer Research, vol. 26, no. 1A, pp. 227-242, 2006.
48. J. B. Patil, J. Kim, and G. K. Jayaprakasha, "Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway," European Journal of Pharmacology, vol. 645, pp. 70-78, 2010.
49. C.-Q. Li and G. N. Wogan, "Nitric oxide as a modulator of apoptosis," Cancer Letters, vol. 226, no. 1, pp. 1-15, 2004.
50. J. Li, T. R. Billiar, R. V. Talanian, and Y. M. Kim, "Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation," Biochemical and Biophysical Research Communications, vol. 240, no. 2, pp. 419-424, 1997.